Brickell Biotech, Inc. Series A Preferred Stock SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENTInvestment Representation Agreement • May 25th, 2022 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT, dated as of May 25, 2022, is by and between Brickell Biotech, Inc., a Delaware corporation (the “Company”), and the undersigned subscriber (the “Subscriber”). In consideration of the mutual promises contained herein, and other good, valuable and adequate consideration, the parties hereto agree as follows:
